VPIM
MIRA icon

Vanguard Personalized Indexing Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,993
Closed -$31.9K – 1890
2024
Q4 		$31.9K Buy
+27,993
New +$36.6K ﹤0.01% 1735

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

Vanguard Personalized Indexing Management's MIRA Position: Q1 2025 in Review

Vanguard Personalized Indexing Management sold out of MIRA Pharmaceuticals (MIRA) in Q1 2025, closing a stake of 27,993 shares — an estimated $31.9K sold.

Vanguard Personalized Indexing Management first reported a position in MIRA in Q4 2024 and held it in 1 quarter. The position peaked at $31.9K in Q4 2024. 19 funds tracked by Wall St. Rank hold MIRA as of Q1 2025.

  • Vanguard Personalized Indexing Management reported no remaining MIRA Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 27,993 MIRA Pharmaceuticals shares in Q1 2025, an estimated $31.9K.
  • Vanguard Personalized Indexing Management first reported a position in MIRA Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's MIRA Pharmaceuticals position peaked at $31.9K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2025, filed 14 May 2025.